Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership $8.99 -0.05 (-0.50%) As of 10:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.89%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$256.05KNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$59.85K Get ENTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENTA Insider Buying and Selling by Quarter Enanta Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/12/2025Jay R LulyCEOBuy45,000$5.69$256,050.00 12/6/2024Jay R LulyCEOSell5,142$8.06$41,444.52 12/6/2024Tara Lynn KiefferInsiderSell2,283$8.06$18,400.98 (Data available from 1/1/2013 forward) ENTA Insider Trading Activity - Frequently Asked Questions Who is on Enanta Pharmaceuticals' Insider Roster? The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Jay R Luly, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA. What percentage of Enanta Pharmaceuticals stock is owned by insiders? 13.89% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings. Which Enanta Pharmaceuticals insiders have been buying company stock? The following insider purchased ENTA shares in the last 24 months: Jay R Luly ($256,050.00). How much insider buying is happening at Enanta Pharmaceuticals? Insiders have purchased a total of 45,000 ENTA shares in the last 24 months for a total of $256,050.00 bought. Which Enanta Pharmaceuticals insiders have been selling company stock? The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($111,069.42), Paul J Mellett ($23,227.56), Scott T Rottinghaus ($161,733.35), Tara Lynn Kieffer ($107,990.76), and Terry Vance ($139,490.40). How much insider selling is happening at Enanta Pharmaceuticals? Insiders have sold a total of 51,961 Enanta Pharmaceuticals shares in the last 24 months for a total of $563,975.24 sold. Enanta Pharmaceuticals Key ExecutivesDr. Jay R. Luly Ph.D. (Age 68)President, CEO & Director Compensation: $1.25MMr. Paul J. Mellett Jr. (Age 69)Chief Financial & Administrative Officer Compensation: $666.84kDr. Yat Sun Or Ph.D. (Age 72)Senior VP of Research & Development and Chief Scientific Officer Compensation: $729.31kMr. Nathaniel S. Gardiner J.D. (Age 70)Consultant Compensation: $672.67kMr. Brendan Luu (Age 49)Chief Business Officer Compensation: $622.86kMs. Jennifer VieraSenior Director of Investor Relations & Corporate CommunicationsMr. Matthew P. Kowalsky J.D. (Age 51)Chief Legal Officer Ms. Tara Lynn Kieffer Ph.D. (Age 46)Chief Product Strategy Officer Compensation: $496.85kDr. Scott T. Rottinghaus M.D. (Age 50)Senior VP & Chief Medical Officer Compensation: $616.73k More Insider Trading Tools from MarketBeat Related Companies NRIX Insider Trading TBPH Insider Trading PROK Insider Trading VIR Insider Trading KURA Insider Trading KALV Insider Trading MNMD Insider Trading TYRA Insider Trading ORGO Insider Trading BCAX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:ENTA) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTA Stock Alerts